The Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) Forum is a translational science meeting focusing on scientific discoveries made in multiple sclerosis (MS) to advance the understanding of research and clinical care of patients with MS. Every third year, it meets collectively with its European counterpart, ECTRIMS.
Mary Rensel, MD: Transitioning to Shared Medical Appointments
April 2nd 2020The director of Pediatric MS and Wellness programming at the Mellen Center and assistant professor of neurology at Cleveland Clinic Lerner College of Medicine discussed the harsh realities of patients adopting a new treatment method.
Le Hua, MD: Subanalysis of the EXPAND Study of Siponimod in SPMS
March 24th 2020The director of the Multiple Sclerosis Program at Cleveland Clinic’s Lou Ruvo Center for Brain Health discussed the findings of a subanalysis of the EXPAND study of siponimod in patients with secondary progressive multiple sclerosis.
Le Hua, MD: Considering Age in Multiple Sclerosis Treatment
March 19th 2020The director of the Multiple Sclerosis Program at Cleveland Clinic’s Lou Ruvo Center for Brain Health discussed the need to take age into consideration when managing a patient with MS, and how the thinking about the disease and age has shifted.
Mary Rensel, MD: Integrating Shared Medical Appointments in MS
March 11th 2020The director of Pediatric MS and Wellness at the Mellen Center and assistant professor of neurology at Cleveland Clinic Lerner College of Medicine describes her study on shared medical appointments and the intricacies of integrating them into the common care realm.
Carrie Hersh, DO, MSc: Measuring Progressive Multiple Sclerosis
March 10th 2020The assistant professor of neurology at the Lerner College of Medicine and neurologist at Luo Ruvo Center for Brain Health, both of Cleveland Clinic, discussed the challenges of current measurements and the need to adjust the reading of progressive MS.
Carrie Hersh, DO, MSc: Addressing Progressive Disease in MS
March 7th 2020The assistant professor of neurology at the Lerner College of Medicine and neurologist at Luo Ruvo Center for Brain Health, both of Cleveland Clinic, spoke to the importance of preventing progression in MS and treating the non-inflammatory aspects of the disease.